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Abstract
Objective: To report a case of a lethal morphine overdose in a breastfed
infant secondary to medication transfer into breast milk.
Case Report: The mother of a 6 ½ week old breastfed infant contacted
emergency services secondary to her child being unresponsive. The infant was
pronounced dead on arrival of medical personnel to the scene, and the mother
reported taking numerous medications including morphine sulfate. Autopsy
of the infant revealed lethal levels of morphine in samples of her tissue. The
mother was charged with homicide, which is the first case of homicide secondary
to medication transfer into breast milk.
Discussion: Medication transfer into breast milk is dependent on many
factors, including size and molecular weight, lipid solubility, protein binding,
and pH. Infant response to the presence of medications in breast milk is
dependent upon age-related pharmacodynamic factors that change weekly in
rapidly growing and maturing infants, specifically volume of distribution, growth
patterns, organ maturation, and digestive abilities. Infants also have a lower
fat concentration, therefore exposure to fat-soluble drugs like morphine have
enhanced blood-brain barrier penetration and ultimate accumulation following
prolonged exposure.
Conclusion: Enhanced awareness of medication exposure to infants via
breast milk is vital to prevent morbidity and mortality. An understanding of the
mechanism of medication transport into breast milk, as well as differences in
infant response to medications based on pharmacodynamics, are crucial in the
medical management of a breastfeeding mother. In order to minimize toxicity to
the breastfeeding infant, utilizing the lowest effective dose for a minimal amount
of time is the cornerstone recommendation.
Keywords: Pharmacodynamics; Lethal morphine; Paracellular; Breast milk

Introduction
In recent years the use of opioid analgesics, including morphine,
has increased among the general population. The CDC reported
in 2013 that for every woman that dies of a prescription painkiller
overdose, 30 go to the emergency department for painkiller abuse or
misuse [1]. Women of childbearing age are the population most likely
to abuse or misuse prescription analgesics [1]. Abuse of prescription
painkillers by pregnant and lactating women can put infants at risk,
including neonatal abstinence syndrome and potential overdose.
Between 2000 and 2009 reports of neonatal abstinence syndrome
grew almost 300% in the United States [1].
Unfortunately there have not been many studies done on the
concentrations of drugs found in the plasma and their relative transfer
into the breast milk of a lactating mother. While the pharmacokinetics
of morphine are known, there are individual characteristics of the
mother and infant that ultimately effect the total concentrations of
drug. The concentration of morphine that is lethal to an infant has not
been well documented and can differ significantly due to age, body
weight, fat distribution, and renal and hepatic enzyme development.
The mother’s metabolism of the drug is another factor that influences
the amount transferred into breast milk. The American Academy
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of Pediatrics (AAP) does consider morphine to be compatible with
breastfeeding [2,3]. However, the AAP also states that an infant may
have measurable blood concentrations of morphine following longterm repeated exposure [4].
We report a case of a lethal morphine overdose in a breastfed
infant whose mother had prescriptions for morphine sulfate, along
with numerous other medications. To our knowledge, this is the first
case of a mother charged with homicide secondary to medication
transfer via breast milk.

Case Report
Emergency services were contacted about a 6 ½ week-old infant
girl who was reportedly unresponsive. The dispatcher instructed
the mother on CPR. Emergency services arrived approximately 12
minutes after 911 was called. The child was pronounced dead on
arrival, and the coroner was requested at the scene. Interview with the
coroner revealed that the mother went to bed breastfeeding the child
around 11 pm the previous night. The father of the infant woke at 5 am
the following morning to find the child cold and unresponsive with
fixed pupils. The mother stated she last breastfed the child around 2
am. The mother also reported that a few days before, the child was
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Table 1: Medications Mother admitted to taking.
Medication

Dose Prescribed

Last Filled

Quantity filled / Quantity remaining

Hydrocodone 7.5 mg – Ibuprofen 200 mg

1 PO TID

8 days prior

90 / 42

Clonazepam 2mg

1 PO TID

8 days prior

90 / 77

levetiracetam 500 mg

1 PO BID

9 months prior

60 / 41

levetiracetam 500 mg

1 PO BID

6 months prior

60 / 27

Baclofen 10 mg

½ to 1 PO TID

8 days prior

90 / 46

Amlodipine Besylate 5 mg

1 QD

3 days prior

30 / 21

Desvenlafaxine

Unknown – no bottle found

Abbreviations: PO: Orally; TID: Three Times Daily; BID: Twice Daily; QD: Every Day

sleeping more than usual and was lethargic with a decreased appetite.
Two days prior to the death, parents called the pediatrician regarding
congestion and “cold” symptoms. Since the child was not running a
fever they did not visit the office but instead were instructed to use a
chest rub and vaporizer. The mother also reported that she gave 0.8
mL of 150 mg/5 mL acetaminophen to the child the night before. She
said she alternated the acetaminophen with ibuprofen, but the exact
dosage of ibuprofen given, if any, was not documented.
During the interview with the coroner the mother was asked
about medications she was currently taking, and she reported that
she was currently prescribed levetiracetam, baclofen, amlodipine,
desvenlafaxine, clonazepam and hydrocodone/ibuprofen. The
prescribed dosages, date of last fill, and tablets remaining in the
bottles are listed in Table 1. Upon search of the residence, prescription
bottles for milancipran, carisoprodol, gabapentin, ropinirole,
morphine sulfate extended release, and caffeine tablets were found.
Details of these medications can be found in Table 2. All prescription
medications found in the residence were prescribed to the mother.
The medication most pertinent to this case is the morphine sulfate
extended release, which she did not admit to taking upon her
interview with the coroner. This medication was originally prescribed
to her in 1998 after a serious car accident that left her with a diagnosis
of chronic pain. Further investigation revealed that the prescriber
of the morphine was unaware that the patient was pregnant and
subsequently breastfeeding an infant. Alternatively, the obstetrician
and pediatrician were unaware that the mother was taking morphine.
Within 24 hours of the death, an autopsy of the infant was
performed and tissue samples including heart blood, liver, and
brain were taken for toxicological analysis. Tissue samples were
prepared as homogenates prior to analysis. Morphine was extracted
from biological samples using solid phase extraction. Extracts were
derivatized and analyzed for free morphine using full scan, gas
chromatography mass spectrometry. The toxicology findings are
listed in Table 3. The post-mortem examination revealed diffuse

acute passive congestion with minor acute intra-alveolar hemorrhage
bilaterally, diffuse multifocal subarachnoid congestion of the brain,
and cerebral edema. Based on the history, autopsy and toxicological
findings, it was determined that the death was the result of respiratory
insufficiency secondary to synergistic drug intoxication.
The mother was charged with homicide by child abuse, involuntary
manslaughter and unlawful conduct towards a child. She was tried
and convicted of all three charges and subsequently sentenced to 20
years in prison, the maximum amount allowable by law for homicide
by child abuse. This case has set precedence for future cases, as it was
the first to ever prosecute a mother for killing her child by substances
transferred through breast milk.

Discussion
Due to the rise in analgesic use among women and the potential
for infant harm, a discussion on medication transfer into breast milk
and infant response to medications is warranted. Milk formation is
complex, however in order to understand the transportation of drugs
into breast milk it is essential to have a basic understanding of how
milk is produced. Breast physiology is markedly changed during
pregnancy due to increases in estrogen and progesterone and in
the post partum period by an elevation in prolactin [5-7]. With the
increase in hormones, there is an increase in the size and number of
alveolar units which are responsible for the production of milk [5,6].
The transfer of drug into breast milk can occur via passive diffusion,
carrier mediated transport and paracellular pathway [6]. Immediately
postpartum, drugs are able to diffuse into the alveolus through the
paracellular pathway due to incomplete closure of junctions between
the mammary alveolar cells [6]. After several days the junctions close
and the paracellular pathway is impeded thereby facilitating passive
diffusion and carrier-mediated transport more readily [6].
There are several factors that affect the transport of drug into the
breast milk. These factors include size and molecular weight, lipid
solubility, protein binding and acid base conditions [5,6]. (Figure 1)

Table 2: Additional Medications found at scene prescribed to Mother.
Last Filled

Quantity filled / Quantity remaining

1PO QHS

8 days prior

90 / 75

1 PO BID

14 days prior

60 / 14

Medication

Dose Prescribed

Ropirinole HCl 1mg
Gabapentin 800 mg
Milnacipran 50 mg

1 PO BID

5 months prior

60 / 55

Carisoprodol 350 mg

1-2 PO BID

1 month and 15 days prior

360 /59

Morphine Sulfate ER 30 mg

1 PO Q8hr PRN

23 days prior

90 / 12

Caffeine Tablets 200 mg

N/A

N/A

16 / 6

Abbreviations: PO: Orally; BID: Twice Daily; QHS: Every Day at Bedtime; Q8hr: Every 8 hours; PRN: as needed
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Table 3: Toxicology report from blood, brain tissue and liver tissue samples of
the infant.
Blood:
Analyte:
Acetaminophen

Diphenhydramine
Chlorpheniramine
Methorphan
Methorphinan
Morphine
Clonazepam

Levels:

Maternal Drug
Dose

•Frequency, total daily dosage and route of administration

Results:

Therapeutic: 10-20 mg/L
Toxic: 150 mg/L
Lethal: > 160 mg/L
Therapeutic: 0.025-0.112mg/L
Toxic: 5 mg/L
Lethal: > 8 mg/L
Therapeutic: 0.01 - 0.017 mg/L
Lethal: 0.5 – 1.7 mg/L
Therapeutic: 0.15 - 0.4 mg/L
Lethal: > 3mg/L
Therapeutic: 0.007-0.021 mg/L
Lethal: 0.8-2.7 mg/L
Therapeutic: 0.1 – 0.3 mg/L
Lethal: 0.1 – 4 mg/L
Therapeutic: 0.007 – 0.028 mg/L
Toxic: 0.46 mg/L

19 mg/L

Maternal Blood
Concentration

0.03 mg/L
Maternal Milk
Concentration

•Factors aﬀecting maternal serum drug concentration include absorption, distribution,
metabolism and elimination of the drug

•Molecular weight, acid base conditions, protein binding and fat solubility determine the
milk-to-plasma ratio.

0.06 mg/L
0.03 mg/L

Infant blood
concentration

•Initial concentration is determined by amount of mother's milk ingested by the infant
•Final blood concentration determined by absorption, distribution, metabolism and
elimination by the infant.

0.04 mg/L
0.52 mg/L

Infant
Eﬀects

•Infants health and pharmacodynamic factors

0.01 mg/L

Brain:

Figure 1: Drug Concentration Cascade from Mother to Infant.
Analyte:

Result:

Morphine

0.64 mg/Kg

Liver:
Analyte:

Result:

Morphine

0.56 mg/Kg
Lethal: 0.4 – 18 mg/Kg (average 3.0 mg/Kg)

Molecules of lower weight will transfer more readily into the breast
milk [5,6]. Human breast milk contains approximately 4% fat, which
is significantly higher than blood fat concentration (<1%) [5,6]. Due
to the heavier concentration of fat in the milk, lipid soluble drugs
may diffuse and become trapped allowing for higher milk-to-plasma
Ratios [5,6]. Protein binding has a two-fold mechanism. Drugs with
high maternal protein binding will accumulate in the maternal plasma
and are less likely to transfer into breast milk [5,6]. Alternatively
drugs with low maternal protein binding may more readily diffuse
into breast milk and bind to milk proteins thereby accumulating in
the breast milk [5,6]. Human milk has a lower pH (7) than serum
(7.35-7.45) [5,6]. Due to milk’s lower pH, ion trapping can occur with
weak bases allowing for higher concentrations in breast milk [5,6].
Individual maternal pharmacodynamic factors can also play a
large role in the concentration of drug available in the breast milk.
Absorption, distribution, metabolism and elimination can vary from
woman to woman depending on genetic, nutritional and health
related factors. Pharmacodynamic factors in infants vary widely from
week to week secondary to rapidly changing volume of distribution,
growth patterns, organ maturation, and digestive abilities. Absorption
in infants is generally slower than that of an adult [6]. Variables
such as gastric pH and intestinal flora are responsible for changes
in absorption [6]. Along with physical variables, the bioavailability
of the drug administered will play a significant role in its absorption
[7]. Body composition affects the distribution of drugs, and when
comparing newborns, infants, and adults they all have vastly different
fat compositions [6]. As aging occurs the percentage of fat in total
body composition increases. Administration of a fat-soluble drug,
such as morphine, to an individual with a lower fat concentration
will enhance accumulation in the brain secondary to increased
penetration of the blood-brain barrier [6,8]. This property could
potentially lead to adverse CNS effects [6,8]. Hepatic enzymes such
as UGT2B7,which are responsible for morphine metabolism, are not
Submit your Manuscript | www.austinpublishinggroup.com

fully active until several months of age. The glomerular filtration
rate in full term newborns is approximately 25% of that in adults not
reaching full potential until 3-5 months of age [6,9]. Due to decreases
in hepatic metabolism and renal excretion, drugs such as morphine
that form glucuronides are subject to longer half-lives in infants (3-14
hours) than their adult counterparts (2-3 hours). In this case only
the free morphine was measured, therefore the contribution from the
glucuronide metabolites is unknown.
The therapeutic, toxic, and lethal ranges reported in Table 3
represent a composite of ranges that have been reported in the
literature. Although there is limited data concerning morphine
exposure in neonates, Robieux et. al. report a case where a neonate
(< 2 week) was exposed to morphine via breast milk. The neonate
developed clinically significant symptoms with a level of 0.004 mg/L
(4 ng/ml) morphine [2]. A 10 month old boy who died following an
exposure to ethylmorphine had postmortem levels of 0.054 mg/L (54
ng/ml) of ethylmorphine and 0.026 mg/L (26 ng/mL) morphine [10].
Additionally, there is a reported case where a 13 day-old neonate
succumbed to a level of 0.07 mg/L (70 ng/mL) of morphine [11]
and another report of an 8 year-old child who died as a result of an
accidental oral ingestion of morphine sulfate with a resulting level of
0.128 mg/L (128 ng/mL)[12]. The range associated with compounds
such as morphine also reflects variances due to tolerance. This range
encompasses both the naïve user (lower end of the range) and the
opioid tolerant user (upper end of the range). Since the frequency
and dose exposure of this infant to morphine is unknown, the level
of tolerance cannot be determined. However, the level of morphine
in the case presented in this paper represents a level that is well above
the levels that have been reported to cause death in adults, children,
and other infants.
One final concern in interpreting the levels of morphine is the
phenomenon of post-mortem redistribution. The heart/femoral
blood concentration ratio for morphine has been reported to be an
average of 1.2 to 2.2 [13]. Again, the level of morphine in this case
is well above the levels that have been associated with death from
morphine intoxication even when considering any redistribution,
and analysis of brain and liver tissue confirm that the infant was
exposed to a lethal amount of morphine.
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Conclusion
This was an unfortunate case of morphine toxicity that was
exacerbated by the combination of other drugs with synergistic activity
leading to CNS and respiratory depression. The bioavailability of
morphine is 17-33% following oral administration. This may explain
why few cases of toxicity have been reported. However in conjunction
with decreased hepatic metabolism and renal excretion in the infant,
morphine concentration could have accumulated. With the infant’s
body composition and repeated exposure, CNS effects were markedly
increased due to the diffusion across the blood-brain barrier.
Additionally, the dose of morphine that this infant received likely
represents a much larger dose than what is usually seen in infants
who are breastfeeding from mothers prescribed opioids post-partum.
In this case, the chronic misuse of extended release morphine by the
breastfeeding mother led to the toxicity seen in this infant.
When considering analgesic treatment for a lactating mother
one must weigh all potential risks to the infant. As always, using the
lowest effective dose for a minimal amount of time is recommended
with any medication in order to minimize the risk of toxicity to the
infant.
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